Overview of Essential Fatty Acids: Types and Applications

Download Article

DOI: 10.21522/TIJPH.2013.13.02.Art047

Authors : Hasan M. Hasan, Zeina Althanoon

Abstract:

Essential fatty acids (EFAs), including omega-3 and omega-6 polyunsaturated fatty acids (PUFAs), are crucial for maintaining cellular function and overall health. As the body cannot synthesize EFAs, they must be obtained through the diet. EFAs play key roles in various physiological processes, such as membrane fluidity, enzyme activity, gene expression, and the production of bioactive lipid mediators like eicosanoids. Omega-3 fatty acids (e.g., alpha-linolenic acid, ALA; eicosapentaenoic acid, EPA; and docosahexaenoic acid, DHA) are particularly noted for their anti-inflammatory, cardioprotective, and neuroprotective properties, while omega-6 fatty acids (e.g., linoleic acid, LA) are involved in inflammatory and immune responses. An imbalance between omega-3 and omega-6 intake, typically skewed towards excessive omega-6 consumption, is associated with an increased risk of chronic diseases such as cardiovascular disease, diabetes, arthritis, and certain types of cancer. Additionally, deficiencies or imbalances in EFAs can impair growth, cognitive function, and immune responses. Recent research has highlighted the importance of optimizing EFA intake for disease prevention and health promotion, particularly through dietary sources like fish, flaxseeds, walnuts, and vegetable oils. This abstract underscores the critical role of EFAs in both maintaining health and mitigating the risk of various chronic conditions.

References:

[1]. Innis, S. M., 2011, Dietary Triacylglycerol Structure and Its Role in Infant Nutrition. Advances in Nutrition, 2, 275–283, Doi:10.3945/An.111.000448.

[2]. Stanley, W. C., Khairallah, R. J., Dabkowski, E. R., 2012, Update on lipids and mitochondrial function: impact of dietary n-3 polyunsaturated fatty acids. Current Opinion in Clinical Nutrition and Metabolic Care, 15, 122–126, Doi:10.1097/Mco.0b013e32834fdaf7.

[3]. Glick, N. R., Fischer, M. H., 2013, The Role of Essential Fatty Acids in Human Health. J Evid Based Complementary Altern Med,18, 268–289, Doi:10.1177/2156587213488788.

[4]. Parker, G., Gibson, N. A., Brotchie, H., Heruc, G., Rees, A. M., Hadzi-Pavlovic, D., 2006, Omega-3 Fatty Acids and Mood Disorders. AJP, 163, 969–978, Doi:10.1176/ajp.2006.163.6.969

[5]. Calder, P. C., 2012, Mechanisms of Action of (n-3) Fatty Acids, The Journal of Nutrition, 142, 592S-599S, Doi:10.3945/jn.111.155259.

[6]. Hibbeln, J. R., Nieminen, L. R., Blasbalg, T. L., Riggs, J. A., Lands, W. E., 2006, Healthy intakes of n−3 and n–6 fatty acids: estimations considering worldwide diversity. The American Journal of Clinical Nutrition, 83, 1483S-1493S, Doi:10.1093/ajcn/83.6.1483S.

[7]. Holick, M. F., 2011, Vitamin D: A D-Lightful Solution for Health. Journal of Investigative Medicine, 59, 872–880, Doi:10.2310/JIM.0b013e318214ea2d.

[8]. Blumberg, J., Heaney, R. P., Huncharek, M., Scholl, T., Stampfer, M., Vieth, R., Weaver, C. M., Zeisel, S. H., 2010, Evidence-based criteria in the nutritional context: Nutrition Reviews, 68(8), 478–484, Doi:10.1111/j.1753-4887.2010.00307.x.

[9]. Saravanan, P., Davidson, N. C., Schmidt, E. B., Calder, P. C., 2010, Cardiovascular effects of marine omega-3 fatty acids. The Lancet, 376, 540–550, Doi:10.1016/S0140-6736(10)60445-X.

[10]. Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., Karanja, N., Lefevre, M., Rudel, L., Sacks, F., Van Horn, L., Winston, M., Wylie-Rosett, J., 2006, Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee. Circulation, 114, 82–96, Doi:10.1161/CIRCULATIONAHA.106.176158

[11]. Rizos, E. C., Ntzani, E. E., Bika, E., Kostapanos, M. S., Elisaf, M. S., 2012, Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events: A Systematic Review and Meta-analysis. JAMA, 308, 1024, Doi:10.1001/2012.jama.11374.

[12]. McNamara, R. K., Carlson, S. E., 2006, Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins, Leukotrienes and Essential Fatty Acids, 75, 329–349, Doi:10.1016/j.plefa.2006.07.010.

[13]. Tan, Z. S., Harris, W. S., Beiser, A. S., Au, R., Himali, J. J., Debette, S., Pikula, A., DeCarli, C., Wolf, P. A., Vasan, R. S., Robins, S. J., Seshadri, S., 2012, Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology, 78, 658–664, Doi:10.1212/WNL.0b013e318249f6a9

[14]. Astarita, G., Jung, K. M., Vasilevko, V., DiPatrizio, N. V., Martin, S. K., Cribbs, D. H., Head, E., Cotman, C. W., Piomelli, D., 2011, Elevated Stearoyl-CoA Desaturase in Brains of Patients with Alzheimer’s Disease. PLoS ONE, 6, e24777, Doi:10.1371/journal.pone.0024777

[15]. Paton, C. M., Ntambi, J. M., 2009, Biochemical and physiological function of stearoyl-CoA desaturase. American Journal of Physiology-Endocrinology and Metabolism, 297, E28–E37, Doi:10.1152/ajpendo.90897.2008.

[16]. Hughes, M. M., Carballedo, A., McLoughlin, D. M., Amico, F., Harkin, A., Frodl, T., Connor, T. J., 2012, Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation. Brain, Behavior, and Immunity, 26, 979–987, Doi:10.1016/j.bbi.2012.05.010.

[17]. Lin, P. Y., Huang, S. Y., Su, K. P., 2010, A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Patients with Depression. Biological Psychiatry, 68, 140–147, Doi:10.1016/j.biopsych.2010.03.018.

[18]. Martins, J. G., 2009, EPA but Not DHA Appears To Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled Trials. Journal of the American College of Nutrition, 28, 525–542, doi:10.1080/07315724.2009.10719785.

[19]. Chen, C. T., Liu, Z., Bazinet, R. P., 2011, Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study: Rapid loss of eicosapentaenoic acid from brain phospholipids. Journal of Neurochemistry, 116, 363–373, Doi:10.1111/j.1471-4159.2010.07116.x.

[20]. Rapoport, S. I., Basselin, M., Kim, H. W., Rao, J. S., 2009, Bipolar disorder and mechanisms of action of mood stabilizers. Brain Research Reviews, 61, 185–209, Doi:10.1016/j.brainresrev.2009.06.003.

[21]. Hibbeln, J. R., Davis, J. M., 2009, Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acids. Prostaglandins, Leukotrienes and Essential Fatty Acids, 81, 179–186, Doi:10.1016/j.plefa.2009.06.005.

[22]. Da Rocha, C. M. M., Kac, G., 2012, High dietary ratio of omega‐6 to omega‐3 polyunsaturated acids during pregnancy and prevalence of post‐partum depression. Maternal & Child Nutrition, 8, 36–48, Doi:10.1111/j.1740-8709.2010.00256.x.

[23]. Sumiyoshi, T., Higuchi, Y., Matsui, M., Itoh, H., Uehara, T., Itoh, T., Arai, H., Takamiya, C., Suzuki, M., Kurachi, M., 2011, Membrane fatty acid levels as a predictor of treatment response in chronic schizophrenia. Psychiatry Research, 186, 23–27, Doi:10.1016/J.Psychres.2010.07.049.

[24]. Amminger, G. P., Schäfer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., Berger, G. E., 2010, Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders: A Randomized, Placebo-Controlled Trial. Arch Gen Psychiatry, 67, 146.

[25]. Smuts, C., 2003, A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstetrics & Gynecology, 101, 469–479, Doi:10.1016/S0029-7844(02)02585-1.

[26]. Szajewska, H., Horvath, A., Koletzko, B., 2006, Effect of n−3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition, 83, 1337–1344, Doi:10.1093/ajcn/83.6.1337.

[27]. Larqué, E., Gil-Sánchez, A., Prieto-Sánchez, M. T., Koletzko, B., 2012, Omega 3 fatty acids, gestation and pregnancy outcomes. Br J Nutr, 107, S77–S84, Doi:10.1017/S0007114512001481.

[28]. Hallmayer, J., 2011, Genetic Heritability and Shared Environmental Factors Among Twin Pairs with Autism. Arch Gen Psychiatry, 68, 1095, Doi:10.1001/archgenpsychiatry.2011.76.

[29]. Richardson, A. J., Burton, J. R., Sewell, R. P., Spreckelsen, T. F., Montgomery, P., 2012, Docosahexaenoic Acid for Reading, Cognition and Behavior in Children Aged 7–9 Years: A Randomized, Controlled Trial (The DOLAB Study). PLoS ONE, 7, e43909, Doi:10.1371/journal.pone.0043909.

[30]. Suzuki, H., Morikawa, Y., Takahashi, H., 2000, Effect of DHA Oil Supplementation on Intelligence and Visual Acuity in the Elderly, in: Hamazaki, T., Okuyama, H. (Eds.), World Review of Nutrition and Dietetics. KARGER, Basel, pp. 68–71, Doi:10.1159/000059767.

[31]. Ouchi, M., Ikeda, T., Nakamura, K., Harino, S., Kinoshita, S., 2002, A Novel Relation of Fatty Acid with Age-Related Macular Degeneration. Ophthalmologica, 216, 363–367, Doi:10.1159/000066178.

[32]. Molfino, A., Amabile, M. I., Monti, M., Muscaritoli, M., 2017, Omega‐3 Polyunsaturated Fatty Acids in Critical Illness: Anti‐Inflammatory, Proresolving, or Both? Oxidative Medicine and Cellular Longevity, 5987082, Doi:10.1155/2017/5987082.

[33]. Gioxari, A., Kaliora, A. C., Marantidou, F., Panagiotakos, D. P., 2018, Intake of ω-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: A systematic review and meta-analysis. Nutrition, 45, 114-124.e4, Doi:10.1016/j.nut.2017.06.023.

[34]. Lassek, W. D., Gaulin, S. J. C., 2011, Sex Differences in the Relationship of Dietary Fatty Acids to Cognitive Measures in American Children. Front. Evol. Neurosci, 3, Doi:10.3389/fnevo.2011.00005.

[35]. Pompili, M., Longo, L., Dominici, G., Serafini, G., Lamis, D. A., Sarris, J., Amore, M., Girardi, P., 2017, Polyunsaturated fatty acids and suicide risk in mood disorders: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 74, 43–56, Doi:10.1016/j.pnpbp.2016.11.007.

[36]. Poudyal, H., Panchal, S. K., Diwan, V., Brown, L., 2011, Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action. Progress in Lipid Research, 50, 372–387, Doi:10.1016/j.plipres.2011.06.003. 

[37]. Rhodes, L. E., Durham, B. H., Fraser, W. D., Friedmann, P. S., 1995, Dietary Fish Oil Reduces Basal and Ultraviolet B-Generated PGE2 Levels in Skin and Increases the Threshold to Provocation of Polymorphic Light Eruption. Journal of Investigative Dermatology, 105, 532–535, Doi:10.1111/1523-1747.ep12323389.

[38]. Alvheim, A. R., Malde, M. K., Osei‐Hyiaman, D., Hong, Y. H., Pawlosky, R. J., Madsen, L., Kristiansen, K., Frøyland, L., Hibbeln, J. R., 2012, Dietary Linoleic Acid Elevates Endogenous 2‐AG and Anandamide and Induces Obesity. Obesity, 20, 1984–1994, Doi:10.1038/oby.2012.38.

[39]. Garaulet, M., Pérez-Llamas, F., Pérez-Ayala, M., Martínez, P., De Medina, F. S., Tebar, F. J., Zamora, S., 2001, Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity, The American Journal of Clinical Nutrition, 74, 585–591, Doi:10.1093/ajcn/74.5.585.

[40]. Nair, S., Lee, Y. H., Rousseau, E., Cam, M., Tataranni, P. A., Baier, L. J., Bogardus, C., Permana, P. A., 2005, Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia, 48, 1784–1788, Doi:10.1007/s00125-005-1868-2